OTCMKTS:IPATFImmunoprecise Antibodies Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Immunoprecise Antibodies Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $1.12 -0.18 (-13.85 %) (As of 07/3/2020 08:56 AM ET) Add Compare Share Today's Range$1.12Now: $1.12▼$1.3050-Day Range$0.58MA: $1.11▼$1.4552-Week Range$0.23Now: $1.12▼$1.52Volume185,641 shsAverage Volume72,776 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartCompetitorsHeadlinesSocial Media ImmunoPrecise Antibodies Ltd. engages in the antibody production and related services in the United States, Canada, and Europe. It also provides human antibody development, hybridoma development, genetic immunization, rabbit monoclonal antibody development, recombinant protein expression and production, cryostorage, hybridoma sequencing, antibody generation, antibody purification, polyclonal development, and peptide production services. The company has a collaboration agreement with TetraGenetics, Inc. to focus on the discovery of novel human monoclonal antibodies against three undisclosed therapeutically-relevant ion-channels. The company was founded in 1989 and is based in Victoria, Canada.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Immunoprecise Antibodies. Previous Next 2.4 Community Rank Outperform VotesImmunoprecise Antibodies has received 25 “outperform” votes. (Add your “outperform” vote.)Underperform VotesImmunoprecise Antibodies has received 27 “underperform” votes. (Add your “underperform” vote.)Community SentimentImmunoprecise Antibodies has received 51.92% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Immunoprecise Antibodies and other stocks. Vote “Outperform” if you believe IPATF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe IPATF will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldImmunoprecise Antibodies does not currently pay a dividend.Dividend GrowthImmunoprecise Antibodies does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Immunoprecise Antibodies insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.48 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:IPATF Previous Symbol CUSIPN/A CIKN/A Webwww.immunoprecise.com Phone250-483-0308Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable OTC:IPATF Rates by TradingView Receive IPATF News and Ratings via Email Sign-up to receive the latest news and ratings for IPATF and its competitors with MarketBeat's FREE daily newsletter. Immunoprecise Antibodies (OTCMKTS:IPATF) Frequently Asked Questions How has Immunoprecise Antibodies' stock been impacted by COVID-19 (Coronavirus)? Immunoprecise Antibodies' stock was trading at $0.53 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, IPATF stock has increased by 111.3% and is now trading at $1.12. View which stocks have been most impacted by Coronavirus. Has Immunoprecise Antibodies been receiving favorable news coverage? Press coverage about IPATF stock has been trending negative on Friday, InfoTrie reports. InfoTrie scores the sentiment of news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Immunoprecise Antibodies earned a media sentiment score of -2.8 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View the latest news about Immunoprecise Antibodies. Who are some of Immunoprecise Antibodies' key competitors? Some companies that are related to Immunoprecise Antibodies include Abattis Bioceuticals (ATTBF), ABcann Global (ABCN), ABZENA/PAR VTG FPD 0.002 (ABZA), Admedus (AHZ), Almirall (LBTSF), Amarantus Bioscience (AMBS), Antibe Therapeutics (VBIZF), Apotheca Biosciences (CBDC), Arno Therapeutics (ARNI), Axim Biotechnologies (AXIM), Baudax Bio (BXRXV), BerGenBio ASA (BRRGF), Biocure Technology (CURE), Canada House Wellness Group (CHV) and Cannabics Pharmaceuticals (CNBX). View all competitors. Who are Immunoprecise Antibodies' key executives? Immunoprecise Antibodies' management team includes the following people: Dr. James S. Kuo M.B.A., M.D., Chairman (Age 54)Dr. Jennifer Bath, Pres, CEO & DirectorMr. Robert Beecroft, Founder & DirectorMr. Charles Wheelock, Global Chief Technology OfficerMs. Lisa Helbling, Chief Financial Officer What is Immunoprecise Antibodies' stock symbol? Immunoprecise Antibodies trades on the OTCMKTS under the ticker symbol "IPATF." How do I buy shares of Immunoprecise Antibodies? Shares of IPATF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Immunoprecise Antibodies' stock price today? One share of IPATF stock can currently be purchased for approximately $1.12. What is Immunoprecise Antibodies' official website? The official website for Immunoprecise Antibodies is www.immunoprecise.com. How can I contact Immunoprecise Antibodies? The company can be reached via phone at 250-483-0308. This page was last updated on 7/3/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
